The impact of pre-existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults

Influenza Other Respir Viruses. 2023 Jul 12;17(7):e13172. doi: 10.1111/irv.13172. eCollection 2023 Jul.

Abstract

Age-associated immune changes and pre-existing influenza immunity are hypothesized to reduce influenza vaccine effectiveness in older adults, although the contribution of each factor is unknown. Here, we constructed influenza-specific IgG landscapes and determined baseline concentrations of cytokines typically associated with chronic inflammation in older adults (TNF-α, IL-10, IL-6, and IFN-γ) in 30 high and 29 low influenza vaccine responders (HR and LR, respectively). In a background of high H3 antibody titers, vaccine-specific H3, but not H1, antibody titers were boosted in LRs to titers comparable to HRs. Pre-vaccination concentrations of IL-10 were higher in LRs compared with HRs and inversely correlated with titers of pre-existing influenza antibodies. Baseline TNF-α concentrations were positively correlated with fold-increases in antibody titers in HRs. Our findings indicate that baseline inflammatory status is an important determinant for generating post-vaccination hemagglutinin-inhibition antibodies in older adults, and IgG responses can be boosted in the context of high pre-existing immunity.

Keywords: antibodies; cytokines; influenza; older adults; vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Viral
  • Humans
  • Immunoglobulin G
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Interleukin-10
  • Tumor Necrosis Factor-alpha

Substances

  • Influenza Vaccines
  • Interleukin-10
  • Tumor Necrosis Factor-alpha
  • Antibodies, Viral
  • Immunoglobulin G